Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about NRX Pharmaceuticals Inc/
Recent news which mentions NRX Pharmaceuticals Inc/
Lab Notes: Imvax advances brain cancer treatment; Wistar identifies promising compound for HIV patients
March 31, 2023
Tickers
INNO
Tags
Ian Tietjen
John P/ Furey
Baudax Bio Inc/
From
Business Journals
Lab Notes: Fox Chase Cancer Center researcher gets $1M grant; NRx raises funds
March 10, 2023
Tickers
INNO
Tags
Biotech
Carisma Therapeutics
Trevena Inc/
From
Business Journals
Lab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapy
December 09, 2022
Tickers
INNO
Tags
Health Care
Insurance
Inno
From
Business Journals
Lab notes: Adaptimmune to reduce workforce; NRx completes $11M debt financing
November 11, 2022
Tickers
INNO
Tags
Pharmaceuticals
Adrian Rawcliffe
Inno
From
Business Journals
NRx Pharmaceuticals on search for new CEO
March 09, 2022
Tags
Patrick Flynn
Jonathan Javitt
Robert Besthof
From
Business Journals
Lab Notes: NRx seeks patent for Covid-19 therapy; Baudax Bio raises $4.2M
January 07, 2022
Tickers
INNO
Tags
Inno
Health Care
Insurance
From
Business Journals
NRx Pharmaceuticals takes second shot a getting emergency use approval for Covid-19 treatment
January 05, 2022
Tags
David Schoenfeld
Pharmaceuticals
Insurance
From
Business Journals
Lab Notes: Penn Medicine's $14M NIH grant; NRx seeks designation for drug candidate
December 30, 2021
Tickers
INNO
Tags
Peter Lebowitz
Carl June
Inno
From
Business Journals
NRx Pharmaceuticals' stock jumps following new analysis of its potential Covid-19 drug
November 29, 2021
Tags
NRX Pharmaceuticals Inc/
Pharmaceuticals
Biotech
From
Business Journals
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.